Photodynamic Therapy 2021

• Muut tekijät: Mordon, Serge (Toimittaja)
• Aineistotyyppi: Elektroninen Kirjan osa
• Kieli: englanti
• Julkaistu: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
• Aiheet: Medicine; Oncology; β-mannose-conjugated chlorin e6; talaporfin sodium; glioblastoma; U251; photodynamic therapy; PDT; laser; ceramics; bacteria; decontamination; cross-linking agents; fluorescent dyes; oxidation reduction; photochemistry; photosensitizing agents; protein conformation; Rose Bengal; protoporphyrin IX; pyropheophorbide-a; Photofrin®; absorption; fluorescence; singlet oxygen; 5-aminolevulinic acid; 5-ALA; dALA; δALA; PpIX; actinic keratosis; illumination time; incubation time; dental implant; peri-implantitis; photoantimicrobial chemotherapy; methylene blue; chitosan; curcumin; natural photosensitizer; skin cancer treatment; squamous cell carcinoma; melanoma; normal keratinocytes; liposomes; glioblastoma multiforme; AGuIX®; terbium; gadolinium; X-ray-induced photodynamic therapy; chemotherapy; zinc (II) phthalocyanine; tin complex; methyl aminolevulinate; riboflavin; ultraviolet radiation; skin tumors; prophylactic treatment; hairless mice; photothermal therapy; radiation therapy; immunotherapy; immune checkpoint inhibition; murine models; clinical trials; programmed death-ligand 1 protein (PD-L1); magnetic nanoparticles; peptide-imprinted polymer; photoinactivation; resistance; antimicrobial agents; SSTI; MDR
• Linkit: DOAB: download the publication; DOAB: description of the publication

Photodynamic therapy (PDT) is a light-based photochemistry process. The illumination of a photoactivatable molecule (also called photosensitizer) with visible or near infrared light produces reactive oxygen toxic species to destroy tumor cells. This treatment modality leads to highly targeted action...